About biobanking
A biobank can be defined as an organized and programed storage of biological materials and corresponding data that can be used in healthcare research. The biological samples vital for medical innovation include tissue, body fluids (such as serum, blood, urine, or fluids from punctures), related derivatives (RNA, DNA, or proteins), and cells.
Technavio’s analysts forecast the global biobanking market to grow at a CAGR of 8.84% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global biobanking market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biobanking.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Biobanking Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Beckman Coulter
• BioCision
• Taylor-Wharton
• Tecan Group
• Thermo Fisher Scientific
• VWR
Other prominent vendors
• Askion
• AstridBio Technologies
• Autoscribe Informatics
• B&C Group
• BioBank
• BioCryo
• BIOGENIC
• BioKryo
• BioLife Solutions
• Biomatrica
• BioreclamationIVT
• BioRep
• Biorep Technologies
• BioStorage Technologies
• BioTillion
• bluechiip
• Brady Worldwide
• Brooks Life Science Systems
• Cell & Co Bioservices
• Cesca Therapeutics
• Chart Industries
• CloudLIMS
• Core Dynamics
• Cryo Bio System
• Cryogatt
• Cryotherm
• CryoXtract
• CSols
• Custom Bio Genic Systems
• Dataworks Development
• DNA Genotek
• Excilone
• FluidX
• Greiner Bio-One International
• HAMILTON storage
• Indivumed
• labmode
• LabVantage Solutions
• LGC Genomics
• LiCONiC
• LVL Technologies
• Micronic
• Modul-Bio
• NorayBio
• Ocimum Biosolutions
• Panasonic Biomedical Sales Europe BV
• Princeton CryoTech
• Promega
• QIAGEN
• RURO
• SINTESY
• SOL Spa
• So-Low Environmental Equipment
• Sysmex
• TECHNIDATA
• Tissue Solutions
• Trans-Hit Bio
• TRINEAN
• Tutela Monitoring Systems
• Wildcat Laboratory Solutions
• Ziath
Market driver
• Increase in funding
• For a full, detailed list, view our report
Market challenge
• Ethical issues
• For a full, detailed list, view our report
Market trend
• Emergence of stem cells storage in biobanks
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Key market highlights
PART 05: Biobanks: An overview
• Types of biobanks
• Classification of commercial biobanks
• List of commercial biobanks
PART 06: Storage conditions
• Controlled room temperature
• Refrigeration
• Frozen
• Ultra-low
• Cryogenic LN2
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Biobank funding and financial stability
• Moving toward cost recovery model
PART 09: Harmonization of biobanking
PART 10: Market segmentation by product
• Global biobanking equipment market
• Market size and forecast
• Global biobanking consumables market
• Market size and forecast
PART 11: Market segmentation by sample
PART 12: Geographical segmentation
• Biobanking market in Americas
• Biobanking market in EMEA
• Biobanking market in APAC
PART 13: Market drivers
• Growing demand for personalized medicine
• Increase in funding
• Increase in efficiency through automation will increase demand
• Reduction in research costs
PART 14: Impact of drivers
PART 15: Market challenges
• Ethical issues
• Lack of standardized procedures coupled with limitations in organ preservation
• Restricted access to samples
• Lack of public trust
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Emergence of stem cells storage in biobanks
• Increasing focus on rare disease research
• Increasing M&A
• Emergence of bio assurance in emerging economies
PART 18: Vendor landscape
• Competitive scenario
• Key news
PART 19: Key vendor analysis
• Beckman Coulter
• BioCision
• Taylor-Wharton
• Tecan Group
• Thermo Fisher Scientific
• VWR
• Other prominent vendors
PART 20: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Workflow of a typical biobank
Exhibit 02: Topology of biobanks
Exhibit 03: Snapshot of global biobanking market
Exhibit 04: Global biobanking market 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis of global biobanking market
Exhibit 06: Five forces analysis
Exhibit 07: Revenue models of biobanks
Exhibit 08: Organizations and their initiatives for biobank harmonization
Exhibit 09: Key factors involved in harmonization of biobanks
Exhibit 10: Key focus areas in harmonization of biobanks
Exhibit 11: Organizations and initiatives in harmonizing science and infrastructure of biobanks
Exhibit 12: Initiatives in biobanking resource tools and databases
Exhibit 13: Global biobanking market segmentation by product
Exhibit 14: Global biobanking market by product 2016 and 2021
Exhibit 15: Global biobanking market by product 2016
Exhibit 16: Global biobanking market segmentation by product type: Growth lifecycle analysis 2016
Exhibit 17: Global biobanking market by product 2016-2021 ($ millions)
Exhibit 18: Global biobanking market by product 2016-2021
Exhibit 19: Global biobanking equipment market 2016-2017 ($ millions)
Exhibit 20: Properties of an efficient sample management system:
Exhibit 21: List of key automated sample storage products
Exhibit 22: List of key automated liquid handling and robotics storage sample products
Exhibit 23: Commercial software used in biobanks
Exhibit 24: Open-source software used in biobanks
Exhibit 25: Global automation equipment market 2016-2021 ($ millions)
Exhibit 26: Global biobanking non-automation equipment market 2016-2021 ($ millions)
Exhibit 27: Global biobanking consumables market 2016-2021 ($ millions)
Exhibit 28: Global biobanking market by sample type
Exhibit 29: Global biobanking market by sample 2016
Exhibit 30: Global biobanking market by geography 2016 and 2021(%)
Exhibit 31: Global biobanking market by geography 2016
Exhibit 32: Global biobanking market by geography: Growth lifecycle analysis
Exhibit 33: Global biobanking market by geography 2016-2021 ($ millions)
Exhibit 34: Global biobanking market by geography 2016-2021 (%)
Exhibit 35: Biobanking market in Americas 2016-2021 ($ millions)
Exhibit 36: Biobanks in Americas
Exhibit 37: Biobanking market in EMEA 2016-2021 ($ millions)
Exhibit 38: Biobanks in EMEA
Exhibit 39: Biobanking market in APAC 2016-2021 ($ millions)
Exhibit 40: List of biobanks in APAC
Exhibit 41: Impact of drivers
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Rare disease research activities
Exhibit 44: Major biobanks in emerging countries
Exhibit 45: Competitive structure analysis of global biobanking market 2016
Exhibit 46: Competitive scenario of vendors in global biobanking market
Exhibit 47: Market share analysis of global biobanking market 2016
Exhibit 48: Competitive landscape analysis of global biobanking market 2016
Exhibit 49: Market penetration of various manufacturers in global biobanking market 2016
Exhibit 50: Strategic factors determining success for companies in global biobanking market
Exhibit 51: Key highlights of Beckman Coulter
Exhibit 52: Beckman Coulter: Strength assessment
Exhibit 53: Beckman Coulter: Strategy assessment
Exhibit 54: Beckman Coulter: Opportunity assessment
Exhibit 55: Key highlights of BioCision
Exhibit 56: BioCision: Strength assessment
Exhibit 57: BioCision: Strategy assessment
Exhibit 58: BioCision: Opportunity assessment
Exhibit 59: Key highlights of Taylor-Wharton
Exhibit 60: Taylor-Wharton: Strength assessment
Exhibit 61: Taylor-Wharton: Strategy assessment
Exhibit 62: Taylor-Wharton: Opportunity assessment
Exhibit 63: Key highlights of Tecan Group
Exhibit 64: Tecan Group: Strength assessment
Exhibit 65: Tecan Group: Strategy assessment
Exhibit 66: Tecan Group opportunity assessment
Exhibit 67: Key highlights: Thermo Fisher Scientific
Exhibit 68: Thermo Fisher Scientific: Strength assessment
Exhibit 69: Thermo Fisher Scientific: Strategy assessment
Exhibit 70: Thermo Fisher Scientific: Opportunity assessment
Exhibit 71: Key highlights of VWR
Exhibit 72: VWR: Strength assessment
Exhibit 73: VWR: Strategy assessment
Exhibit 74: VWR: Opportunity assessment
